Back
Rocket Pharmaceuticals Vs. Fate Therapeutics Industry Stock Comparison
Buy
56
RCKT
Rocket Pharmaceuticals
Last Price:
26.91
Seasonality Move:
4.85%
Sell
43
FATE
Fate Therapeutics
Last Price:
7.34
Seasonality Move:
-7.49%
Buy
56
Rocket Pharmaceuticals (RCKT)
is a Buy
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $26.92. The Score for RCKT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- RCKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $7.34. The Score for FATE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $26.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight selling pressure.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $7.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FATE is experiencing slight selling pressure.
RCKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 44.51 | Sell |
Chaikin Money Flow: | -40195 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.77 - 29.13) | Sell |
Bollinger Bands (100): | (23.76 - 30) | Buy |
FATE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 53.44 | Buy |
Chaikin Money Flow: | -1289243 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.91 - 7.77) | Sell |
Bollinger Bands (100): | (2.79 - 6.85) | Buy |
RCKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.16 | Sell |
20-day SMA: | 27.53 | Sell |
50-day SMA: | 28.34 | Sell |
200-day SMA: | 22.73 | Buy |
8-day EMA: | 27.1 | Sell |
20-day EMA: | 27.54 | Sell |
50-day EMA: | 27.74 | Sell |
200-day EMA: | 24.2 | Buy |
FATE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.11 | Buy |
20-day SMA: | 7.4 | Sell |
50-day SMA: | 6.63 | Buy |
200-day SMA: | 4.02 | Buy |
8-day EMA: | 7.18 | Buy |
20-day EMA: | 7.18 | Buy |
50-day EMA: | 6.5 | Buy |
200-day EMA: | 5.8 | Buy |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.29 per share, and an increase next year of $0.88 per share.
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.
Rocket Pharmaceuticals Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fate Therapeutics Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |